220 related articles for article (PubMed ID: 29356784)
1. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
Bakr O; Zhao W; Corley D
J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.
Nason KS; Wichienkuer PP; Awais O; Schuchert MJ; Luketich JD; O'Rourke RW; Hunter JG; Morris CD; Jobe BA
Arch Surg; 2011 Jul; 146(7):851-8. PubMed ID: 21768433
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
Almers LM; Graham JE; Havel PJ; Corley DA
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
[TBL] [Abstract][Full Text] [Related]
6. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
7. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians.
Shaheen NJ; Weinberg DS; Denberg TD; Chou R; Qaseem A; Shekelle P;
Ann Intern Med; 2012 Dec; 157(11):808-16. PubMed ID: 23208168
[TBL] [Abstract][Full Text] [Related]
8. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.
Veugelers PJ; Porter GA; Guernsey DL; Casson AG
Dis Esophagus; 2006; 19(5):321-8. PubMed ID: 16984526
[TBL] [Abstract][Full Text] [Related]
9. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
10. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and the risk of Barrett's esophagus.
Kubo A; Levin TR; Block G; Rumore G; Quesenberry CP; Buffler P; Corley DA
Cancer Causes Control; 2009 Apr; 20(3):303-11. PubMed ID: 18853262
[TBL] [Abstract][Full Text] [Related]
12. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
Drahos J; Ricker W; Pfeiffer RM; Cook MB
Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
15. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
[TBL] [Abstract][Full Text] [Related]
17. Age at onset of GERD symptoms predicts risk of Barrett's esophagus.
Thrift AP; Kramer JR; Qureshi Z; Richardson PA; El-Serag HB
Am J Gastroenterol; 2013 Jun; 108(6):915-22. PubMed ID: 23567358
[TBL] [Abstract][Full Text] [Related]
18. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
[TBL] [Abstract][Full Text] [Related]
19. Risk of GERD-Related Disorders in Obese Patients on PPI Therapy: a Population Analysis.
Erridge S; Moussa OM; Ziprin P; Darzi A; Purkayastha S
Obes Surg; 2018 Sep; 28(9):2796-2803. PubMed ID: 29717405
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]